Company descriptionNovo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
In the Philippines, Novo Nordisk started its operations in 1976 under the umbrella organization of its distributor. In 1999, steps were taken to establish an affiliate office in the Philippines with the vision of making Novo Nordisk a market leader in its areas of expertise. In June 30, 1999, the Philippine Office was finally able to obtain approval from the Securities and Exchange Commission to operate as an independent Pharmaceutical Company.
We offer products and services in the following therapy areas: Diabetes Care, Coagulation management, Growth hormone therapy, and Hormone replacement therapy.
Contact details:
Address: 21st Floor Twenty Four Seven McKinley Bldg.
24th Street, corner 7th Avenue,
1634 Bonifacio Global City, Taguig City
Philippines
Tel: +63 2 234 3500
Fax: +632 234 3590
Website: http://www.novonordisk.com
Given that Asia is leading growth in the global pharmaceutical market, how is Novo Nordisk represented in the Asia-Pacific region and what is the importance of the Philippines within the…
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma, Indonesia’s largest pharma company; Novavax’s vaccine manufacturing plans in the Philippines; the promising future of…
Ramon Aristoza, acting President and CEO of PhilHealth, discusses the current challenges the organization is facing in terms of realizing the goal of universal healthcare for the Filipino population, their…
The election of maverick former mayor of Davao, Rodrigo Duterte to the Filipino presidency in May 2016 represented a dramatic departure from politics as usual and raised interesting questions about…
Ravinder S. Singha, the Managing Director of Firmlink Pharma, discusses the unique business model they offer to their clients, their key success factors in entering new and sometimes challenging markets,…
Jingle Garcia Diola, Executive Director at Firmlink Pharma, details the company’s value-added services and how they are positioning themselves as the business development partner of choice for large local and…
Javish Abichandani, Chief Executive Officer of AGlobal Care Inc. in the Philippines, outlines the company’s extensive product portfolio as well as their ambitions to bring more high-quality, affordable medications into…
Jose Augusto Pascual, President and CEO of PascualLab, sheds light on the company’s current footprint in the Philippines, as well as their ambitions to even further expand their manufacturing capabilities.…
Cheryl Maley, General Manager of Novartis Philippines, discusses the company’s operations in the country, their growing portfolio of products as well as their impressive focus on research and development in…
Meneleo Hernandez, Jr., President of Multicare, describes Lupin Pharma’s Multicare operations in the Philippines and how their niche business unit strategy and strategic partnerships create a sustainable business model that…
Ivan Alexi Arota, country manager of GE Healthcare Philippines, discusses the company’s extensive efforts to increase access to their innovative, affordable products throughout the country. He also expands on the…
Bakhuti Shengelia, Director Healthcare Systems of Novartis International AG, expands on Novartis’ initiatives to increase access to healthcare in emerging markets as well as the importance of transitioning towards value-based…
See our Cookie Privacy Policy Here
